|This message contains images. If you don't see images, click here to view.|
Advertise in this news brief.
We wanted you to be aware that the FDA has granted accelerated approval of IBRANCE® (palbociclib) for the treatment of postmenopausal women with ER+/HER2- advanced breast cancer. Click here to see the press release!
We wanted you to be aware that FDA-approved Hysingla™ ER (hydrocodone bitartrate) extended-release tablets CII has commercially launched in the U.S.
Please click here to view the press release.
Click here for a CME/CEU activity on Improving Treatment of Atrial Fibrillation and Stoke
Otezla® (apremilast) is approved for the treatment of patients with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy. Please click here for more information.
Click here to view our Complimentary Online CME/CEU Webcasts
OAs part of APhA's longstanding and ongoing commitment to helping its members ensure optimal and safe patient use of prescription medications, nonprescription products, and dietary supplements, APhA convened national pharmacy and medicine leaders and other stakeholders on March 26.
Click here for more information
Click Here to visit the Population Health Management Institute
Experts see big price hikes for Obamacare
The cost of Obamacare could rise for millions of Americans next year, with one insurer proposing a 50 percent hike in premiums, fueling the controversy about just how “affordable” the Affordable Care Act really is.
The eye-popping 50 percent hike by New Mexico insurer Blue Cross Blue Shield is an outlier, and state officials may not allow it to go through.
What's going on with spending on health insurance overhead?
The Wall Street Journal
Even as federal regulators take steps to constrain administrative spending by private health insurers, government overhead on health coverage has soared. In a Health Affairs post, David Himmelstein and Steffie Woolhandler use actuarial estimates from the Centers for Medicare and Medicaid Services to project that between 2014 and 2022, national spending on private insurance overhead and government administration will rise by $273.6 billion related to the healthcare overhaul.
Think you've got good health insurance? Think again
New York Observer
You’ve worked hard to get where you are. You have your dream job with a full benefits package, including healthcare all taken care of, right? But did you read the fine print? Did you ask the right questions about the reality of your coverage? Well you should.
Some might say we’ve come a long way when it comes to health insurance. About 88 percent of the American population has medical insurance coverage, still leaving about 12 percent without, according to a Gallup survey published earlier this year.
ACCOUNTABLE CARE ORGANIZATIONS
Interest in Medicare ACOs could hinge on rule expected soon
The CMS is expected to issue final regulations soon that could significantly affect whether hospitals and doctors remain willing to participate in Medicare's accountable care program.
The Medicare Shared Savings Program for accountable care organizations provides incentives for hospitals and doctors to manage the medical cost and quality for a patient group.
BioFeedback for immunoglobulin is a health outcomes reporting program that provides clinical feedback on the use of immunoglobulin in autoimmune-related disorders. Physicians and medical directors can now deploy clinical interventions when they have the greatest impact on healthcare quality and costs.
Request more information or schedule a personal introduction.
Obamacare's 'accountable care' experiment is all hype, no substance
Good news about Obamacare keeps coming out of the White House. In May, the Department of Health and Human Services announced that the law’s “Pioneer Accountable Care Organizations” have saved Medicare $385 million. HHS Secretary Sylvia Burwell proudly proclaimed that this “innovative payment model”has produced “substantial savings,” so she’s now calling for its expansion.
FDA: NEW TREATMENTS & TECHNOLOGY
'Viagra for women' gets push for FDA approval
The New York Times
Is sexual desire a human right? And are women entitled to a little pink pill to help them feel it?
Those questions are being raised in a campaign that is pressing the Food and Drug Administration to approve a pill aimed at restoring lost libido in women. The campaign, backed by the drug’s developer and some women’s groups, accuses the FDA of gender bias for approving Viagra and 25 other drugs to help men have sex, but none for women.
FDA: Cosmetic face 'fillers' can go wrong
Cosmetic facial fillers, which can plump thin lips or erase wrinkles, can go badly and tragically wrong, the Food and Drug Administration warned.
If the materials used to fill the skin get into a blood vessel, they can cause a stroke, blindness, or kill off big patches of skin, the FDA says in a new warning.
"Unintentional injection can block blood vessels and restrict blood supply to tissues," the FDA says in its warning to consumers and doctors.
Click Here to visit the Genomics, Biotech & Emerging Medical Technology Institute
Quick to laugh or smile? It may be in your genes
Why do some people immediately burst into laughter after a humorous moment, while others can barely crack a smile? New research examining emotional reactivity suggests one of the answers may lie in a person's DNA. In a new study linking a gene to positive emotional expressions such as smiling and laughing, researchers demonstrated that people with a certain genetic variant — those with short alleles of the gene 5-HTTLPR — smiled or laughed more while watching cartoons or subtly amusing film clips than people with long alleles.
17 percent of our genetic knowledge is wrong
Your genes are not your fate.
Nonetheless, genes can tell us a lot about our risk for disease, and sometimes they can tell us how to lead healthier lives.
The landscape of the human genome is vast and mostly unexplored. There is far, far more that we don’t know than we do know. This is why it’s so important that as we test people for genetic mutations, we share information as much as possible.
Ranked #1 in the Nation for Quality of Care.
Our Meaningful Use certified software is designed by medical providers, making SOAPware the preferred EHR for medical professionals!
To find out how to feature your company in the NAMCP eNewsletter and other advertising opportunities, Contact Geoffrey Forneret at 469-420-2629.
Sex chromosomes: Why the Y genes matter
Several genes have been lost from the Y chromosome in humans and other mammals but essential Y genes are rescued by relocating to other chromosomes, according to a new study.
The Y chromosome is dramatically smaller than the X chromosome and has already lost nearly all of the 640 genes it once shared with the X chromosome.
Click Here to visit the Center for Preventive Health and Lifestyle Medicine
Contact lenses may be changing the bacteria in your eyes
The Huffington Post
Wearing contact lenses may change the community of bacteria living in your eyes, according to a small new study. In the study, the surface of the eye in the people who wore contact lenses had triple the proportion of certain bacteria species, on average, compared with the people in the study who did not wear the lenses, researchers found.
Who's drinking the most soda across the US?
By Archita Datta Majumdar
American Dairy Queen Corp. (or DQ as it is popularly known) has vowed to remove all carbonated soft drinks from its kid's menu by September. DQ is not the first to do so, but yet another fast food joining the nutrition bandwagon is clear indication of how concerned Americans are about their children's health. Despite this recent progress, it seems we really have a long way to go before we can truly call ourselves a healthy nation.
Click Here to visit the Oncology Institute
Researchers hail new cancer treatment: Unlocking the body's immune system
Researchers meeting in Chicago are hailing what they believe may be a potent new weapon in the fight against cancer: The body's own immune system.
An international study found that a combination of two drugs that helped allow the immune system to fight the cancer — ipilimumab and nivolumab — stopped the deadly skin cancer melanoma from advancing for nearly a year in 58 percent of the cases.
Click Here to visit the Behavioral Health Institute
You're more likely to have this mental disorder than cancer
While most people try to do everything they can to avoid heart attacks, cancer or diabetes, there's a more common health issue they should be aware of — anxiety disorders. According to a new study, nearly 13 million Americans suffered from an anxiety disorder in the past year, which makes it eight times more common than all cancer cases in the U.S. combined.
Missed last week's issue? See which articles your colleagues read most.
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063